Researchers find molecular signal that could help confirm early diagnosis of multiple sclerosis

By the time multiple sclerosis is normally diagnosed—when brain lesions appear on magnetic resonance imaging scans—the patient can have irreversible damage and treatment options can be limited. But in a Stanford Medicine-led study, researchers found a molecular signal that could help confirm diagnosis of multiple sclerosis early and dramatically improve treatment through sensitive, real-time monitoring of patients’ therapeutic response.

Haabazoka doubts Vedanta Prospects

By NATION REPORTER 

THE downgrading of Vedanta Resources from being stable to negative by S&P Global Ratings is a signal that the Anil Agarwal-owned company may not be a good partner to take up the ownership of Konkola Copper Mine (KCM), renowned economist Lubinda Haabazoka has observed.

This content is locked

This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.


Antimicrobial resistance poses threat in all 35 countries in the Americas

A total of 569,000 deaths have been linked to bacterial antimicrobial resistance (AMR) in all 35 countries of the WHO Region of the Americas, according to a new peer-reviewed paper published in The Lancet Regional Health—Americas. This analysis on the burden of AMR in the Americas is the most comprehensive yet for the region, providing data for 35 countries, 23 bacterial pathogens, and 88 pathogen-drug combinations.